ATGen's IPO

ATGen raised a round of funding on October 23, 2015. Investors include Public.

ATGen (에이티젠) (KOSDAQ: 182400) is focused on manufacturing and providing a substantial list of recombinant proteins and monoclonal antibodies to over 200 research institutes in over 20 differen…

Articles about ATGen's IPO: